Skip NavigationSkip to Content

IFN-gamma: A cytokine at the right time, is in the right place

  1. Author:
    Burke,Daniel
    Young,Howard
  2. Author Address

    Frederick Natl Lab Canc Res, Leidos Biomed Res Inc, AIDS & Canc Virus Program, Frederick, MD 21701 USA.NCI, Lab Expt Immunol, Canc & Inflammat Program, Ctr Canc Res, Frederick, MD 21701 USA.
    1. Year: 2019
    2. Date: JUN
  1. Journal: Seminars in immunology
  2. ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD,
    1. 43
    2. Special Issue: SI
  3. Type of Article: Review
  4. Article Number: 101280
  5. ISSN: 1044-5323
  1. Abstract:

    Interferon gamma has long been studied as a critical mediator of tumor immunity. In recent years, the complexity of cellular interactions that take place in the tumor microenvironment has become better appreciated in the context of immunotherapy. While checkpoint inhibitors have dramatically improved remission rates in cancer treatment, IFN-gamma and related effectors continue to be identified as strong predictors of treatment success. In this review, we provide an overview of the multiple immunosuppressive barriers that IFN-gamma has to overcome to eliminate tumors, and potential avenues for modulating the immune response in favor of tumor rejection.

    See More

External Sources

  1. DOI: 10.1016/j.smim.2019.05.002
  2. PMID: 31221552
  3. WOS: 000504666700003

Library Notes

  1. Fiscal Year: FY2018-2019
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel